CPCR Medical Director, Dr. Sandeep Nayak spoke on a panel yesterday with Jada Pinket Smith at the Not Alone Summit in Las Vegas, discussing psychedelics and mental health

Dr. David Yaden will be speaking at MGH’s Psychedelics & Psychedelic Medicine Conference (Nov 14–15, virtual). Learn the latest research + earn CME/CE. Use code NET50 to save $50. Register: lms.mghcme.org/VirtualPsych...

Can psychedelics help us understand disease-related hallucinations? CPCR post doc Dr.Nate Heller @nate-h-heller.bsky.social explores how serotonin receptors might bridge psilocybin and Parkinson’s in @psychologytoday.com www.psychologytoday.com/us/blog/illu...

Last week, Drs. Weiss and Yaden joined a Humanities on the Hill panel after the film In Waves and War, discussing the impact of war on Veterans and the promise of psychedelic therapies, alongside Marcus Capone, Paul Shenk, and Dr. Virginia Jewiss.

‼️Healthy Volunteers Needed‼️ Join our Johns Hopkins study on how psilocybin affects the brain using safe, noninvasive methods (EEG, fMRI, TMS, cognitive testing). Apply or learn more: tinyurl.com/34jnz3d5 ☎️ 410-550-2253 | ✉️ [email protected]

CPCR members (Fred Barrett, Jessica Dyal, Tess Richardson) attended the kickoff meeting for Reunion Neuroscience’s REKINDLE trial, which will test RE-104—a shorter-acting psilocybin-like compound—for adjustment disorder. Stay tuned for recruitment updates!

🎬 Free Screening: In Waves and War — a documentary on three former Navy SEALs’ journeys with psychedelic therapy. 🗣️ Panel with Director Jon Shenk, Drs. Brandon Weiss & Bit Yaden, and Marcus & Amber Capone (VETS). 📅 Wed, Oct 29 | 6 PM 📍 JHU Bloomberg Center, DC 🎟️ Register Free

Dr. Fred Barrett presented preliminary data on psilocybin’s efficacy for treating depression with co-occurring alcohol use disorder and its underlying therapeutic mechanisms at the 38th annual ECNP Congress in Amsterdam.

🚨 There are limited spots left to attend the SfN Psychedelic Research Event 🧠 Join us before #SfN2025 (Friday, Nov 14) for a deep dive into cross-species psychedelic neuroscience. Register + speaker profiles👇 hopkinspsychedelic.org/sfn2025

Welcome our new postdoctoral research fellow, Dr. Eddie Jacobs. Dr. Jacobs comes to us from Oxford where he investigated ethical aspects of psychedelic therapies. At the CPCR, his work will explore how pre-existing worldviews & beliefs influence the quality and character of psychedelic experiences

🎙️ New podcast from @undarkmag: Dr. Albert Garcia-Romeu, joins Harvard’s Dr. Bertha Madras to discuss what we really know about psychedelics as medicine. 🔗 undark.org/2025/10/01/p...

🧠 New Psychedelic Article in Schizophrenia Bulletin! We argue that visual hallucinations in psychedelics and Lewy body disease may share common mechanisms ⇒ visual degradation & cortical excitation. academic.oup.com/schizophreni... Excited to see this spark discussion! #Neuroscience #Psychedelics

How do psychedelics help treat depression, anxiety, and addiction? In this #ECNP2025 preview, Drs. Linda Simmler and Frederick Barrett discuss psychedelic-induced plasticity with host Friederike Holze. 📅 See them live Oct 14, 2025, 8:40–10:00 🎧 www.youtube.com/watch?v=6FT2...

Dr. Brandon Weiss recently met with congressional staff, NIH, and federal regulators to discuss Veteran health and the importance of rigorous research in guiding safe, responsible psychedelic therapies.

🚨 ATTN SfN attendees: Join our pre-SfN event “The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience.” Limited spots—register now! 👉 hopkinspsychedelic.org/sfn2025

1/ New consensus statement just dropped on the potential for psilocybin in clinical care, from the Task Group on Psychedelics and Related Compounds of the US National Network of Depression Centers The message? Lots of promise, but real risks if we rush. 🧵 authors.elsevier.com/sd/article/S...

🌿 Can psychedelics help with long-COVID & Lyme? Join Dr. Albert Garcia-Romeu (JHU) + an expert panel as they share new research & lived experiences. Free online event! 🔗https://us02web.zoom.us/meeting/register/vg5di-PqS6Ko-GOFOL4Ljg #CPCR #PsychedelicResearch #LongCOVID #LymeDisease

Have you used psychedelics and cannabis on separate occasions? Take our survey! tinyurl.com/psyches-cann... Your responses help advance research on their effects, risks, and benefits.

Microdose interview with Dr. Azin Bekhrad, who runs the Johns Hopkins Clinic for Post-Psychedelic Difficulties themicrodose.substack.com/p/treating-p... (

Our research center is seeking a casual therapist to support cutting-edge studies on the therapeutic effects of psychedelics. Join a team at the forefront of mental health research. Apply below 👇 jobs.jhu.edu/job/Baltimor...

CPCR Faculty David Yaden (@existwell) visited the Uehiro Oxford Institute at Oxford University, advancing work on well-being and the ethics of psychedelics.

Missed our summer newsletter? Catch up on the latest updates from the CPCR and subscribe to stay in the loop: 🔗 hopkinspsychedelic.org/newsletters

Six years ago, our psychedelic center was founded on 20+ years of pioneering research. Today, we’re one of the world’s largest academic hubs in the field—driving innovation, clinical research, and collaboration. Here’s to six years of impact, and many more ahead!

New study from Dr. Brandon Weiss (CPCR) finds UK public attitudes toward psychedelic-assisted therapy are mostly neutral with a slight negative tilt. Published in the International Journal of Drug Policy

Have you used psychedelics and cannabis on separate occasions? Take our survey! tinyurl.com/psyches-cann... Your responses help advance research on their effects, risks, and benefits.

🚨 Research Spotlight 🚨 On Aug 20, Assistant Professor Dr. Brandon Weiss presented to SAMHSA on psychedelic therapeutic models, including his team’s upcoming MDMA + psilocybin trial for PTSD in Veterans.

Check out the latest primer in NPP-Digital Psychiatry and Neuroscience (@dpn_journal), where Dr. Albert Garcia-Romeu explores key debates and unresolved questions in the rapidly evolving field of psychedelic therapy and research. www.nature.com/articles/s44...

Former CPCR postdoc Dr. Jérémie Richard has joined the University of Ottawa as an Assistant Professor in the School of Psychology. He will teach graduate courses in Clinical Psychology and Psychedelic Studies while advancing research on psychedelics and health. Congratulations, Dr. Richard! 🎉

Join us for a webinar with Dr. Albert Garcia-Romeu, presenting on Wednesday, August 20th from 12–1 PM PT, hosted by the USC Institute for Addiction Science in Los Angeles, CA. 📍 Registration is required: us02web.zoom.us/webinar/regi...

The Johns Hopkins Center for Psychedelic and Consciousness Research is committed to public education. Join for Understanding Psychedelic Experiences with Dr. David Yaden at Profs and Pints in Baltimore, MD. 📅 Tue, Aug 19 at 6 PM 📍 The Perch, 1110 S Charles St 🎟️ $13.50 adv | $17 door ($15 student)

📢 Now Recruiting: Research Study on Psilocybin for Depression in Early Alzheimer’s Disease: Psilocybin for depression in early Alzheimer’s/MCI. Receive treatment & free counseling in a safe setting. Sign up: hopkinspsychedelic.org/alzheimers

Do you struggle with chronic low back pain and depression? We are seeking individuals with chronic low back pain and co-occurring depression to see if psilocybin can help! Find out more and click the link below to apply! hopkinspsychedelic.org/backpain

Our research center is seeking a casual therapist to support cutting-edge studies on the therapeutic effects of psychedelics. Join a team at the forefront of mental health research. Apply here 👉 jobs.jhu.edu/job/Baltimor...

Special event Wed 7/30! Dr. David Yaden will discuss the Archives project, where we set out to create the world’s largest database of psychedelic and psychedelic-like experiences, and why this matters! Email Brooklyn Arroyo ([email protected]) to join!

CPCR faculty and postdocs attended an excellent scientific conference on psychedelics at @GordonConf where they presented recent findings. Special thanks to organizers @kwanalexc & @VVyazovskiy #GRCPsychedelics

Experts call for clearer informed consent in psychedelic research as the field grows. A new paper by PhD student Katherine Cheung and CPCR faculty David Yaden urges stronger safeguards to protect participants from complex psychological effects. x.com/Katherine_Ch...

We are seeking veterans who have experience with psilocybin and MDMA to fill out a brief 5-10 minute survey about their experiences. Click the link below to contribute to our research 👇 jhmi.co1.qualtrics.com/jfe/form/SV_...

CPCR faculty David Yaden (@existwell.bsky.social‬) presented and participated in a panel on The Evolving Theory for Explaining Psychedelic Drug Action with Mark Geyer, Harriet de Wit, Franz Vollenweider, Bryan Roth, and Scott Thompson at #GRCPsychedelics

Thrilled to connect at the Neurobiology of Psychedelics Gordon Research Conference next week! CPCR researchers and fellow scientists will discuss wide range of topics, including preclinical and clinical research, drug discovery, and neuroplasticity.

‼️ NEW STUDY FOR HEALTHY VOLUNTEERS ‼️ Join our study at Johns Hopkins exploring how psilocybin affects brain activity and function. Our study uses noninvasive brain imaging methods including EEG, fMRI, TMS, & cognitive testing to better understand effects. Learn more and apply: tinyurl.com/5dc3w4hf

Interested in becoming a psychedelic therapist? We’re seeking a full-time therapist to join our team and support innovative clinical trials exploring the therapeutic potential of psychedelics. Learn more and apply here: jobs.jhu.edu/job/Balitmor...

That’s a wrap on Psychedelic Science 2025! We had a fantastic time presenting our research and connecting with both new and familiar faces in the field. Grateful for the conversations, collaborations, and inspiration. Excited for what’s ahead!

Do you have experience with psychedelic integration? Share your knowledge and experiences in the anonymous questionnaires below to help advance our understanding of how to promote healing, growth, and transformation through psychedelic integration. www.psychedelicintegrationstudies.com

Dr. Brandon Weiss, Assistant Professor, contributed a thoughtful and compassionate perspective to the "Military Voices" panel at last week's Federal Summit on Psychedelic Medicine, which hosted attendees across various sectors including federal policymaking, science, medicine, and industry.

CPCR postdoc Sean Goldy (@seangoldy.bsky.social) spoke at the Centre for Psychedelic Research at Imperial College London and University of Edinburgh, presenting research on psychedelics’ acute subjective effects (e.g., awe), how session facilitators might shape these, and an upcoming trial

Join our brain stimulation research study! Scan the QR code or use the information below to learn more and apply! 410-550-2253 [email protected]

CPCR faculty Dr. Albert Garcia-Romeu was interviewed by Dr. Gillian Beauchamp for the American College of Medical Toxicology's "Tox in Ten" podcast to discuss the history of psychedelic use, current treatment protocols, and research on psychedelics to support recovery from substance use disorders.

Deadline TODAY to apply to Psychedelic Science Postdoctoral Fellowship at the Center for Psychedelic and Consciousness Research with CPCR Faculty David Yaden (@existwell.bsky.social) and Sandeep Nayak. Dual degrees (MD/PhD) preferred–but all excellent candidates considered.

CPCR Associate Center Director Albert Garcia-Romeu will be presenting at the upcoming APA workshop, “The Science of Psychedelics: Research, Risks, and Therapeutic Potentials.” 🔗 Learn more: www.apa.org/events/washi...

CPCR faculty David Yaden (@existwell.bsky.social) spoke with Johns Hopkins Medicine to discuss evidence-based messaging about psychedelic research, informed consent, and adverse events surveillance. Read it here: www.hopkinsmedicine.org/news/article...